1. Analysing the efficacy and tolerability of dolutegravir plus either rilpivirine or lamivudine in a multicentre cohort of virologically suppressed PLWHIV. (22nd October 2022) Authors: Ciccullo, A; Baldin, G; Borghi, V; Cossu, M V; Giacomelli, A; Lagi, F; Farinacci, D; Iannone, V; Passerotto, R A; Capetti, A; Sterrantino, G; Mussini, C; Antinori, S; Di Giambenedetto, S Journal: Journal of antimicrobial chemotherapy Issue: Volume 78:Number 1(2023) Page Start: 117 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Chronic cryptosporidiosis in patients with AIDS: stable remission and possible eradication after long-term, low dose azithromycin. Issue 2 (February 1998) Authors: Dionisio, D; Orsi, A; Sterrantino, G; Meli, M; Di Lollo, S; Ibba Manneschi, L; Trotta, M; Pozzi, M; Sani, L; Leoncini, F Journal: Journal of clinical pathology Issue: Volume 51:Issue 2(1998) Page Start: 138 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Effectiveness, safety, durability and immune recovery in a retrospective, multicentre, observational cohort of ART-experienced, HIV-1-infected patients receiving maraviroc. (October 2017) Authors: Dentone, C; Sterrantino, G; Signori, A; Cenderello, G; Guerra, M; De Leo, P; Bartolacci, V; Mantia, E; Orofino, G; Giacomini, M; Bruzzone, B; Francisci, D; Di Biagio, A Journal: International journal of STD & AIDS Issue: Volume 28:Number 11(2017:Nov.) Page Start: 1067 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Efficacy and safety of switching to dolutegravir plus emtricitabine/tenofovir disoproxil fumarate (TDF) or elvitegravir/cobicistat/emtricitabine/TDF in virologically suppressed HIV‐infected patients in clinical practice: results from a multicentre, observational study. Issue 2 (20th November 2018) Authors: Baldin, G; Ciccullo, A; Capetti, A; Rusconi, S; Sterrantino, G; Cossu, MV; Giacomelli, A; Lagi, F; Latini, A; Bagella, P; De Luca, A; Di Giambenedetto, S; Madeddu, G Journal: HIV medicine Issue: Volume 20:Issue 2(2019) Page Start: 164 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Efficacy and tolerability of lamivudine plus dolutegravir as a switch strategy in a multicentre cohort of patients with suppressed HIV‐1 replication. Issue 7 (24th March 2018) Authors: Borghetti, A; Baldin, G; Lombardi, F; Ciccullo, A; Capetti, A; Rusconi, S; Sterrantino, G; Latini, A; Cossu, MV; Gagliardini, R; De Luca, A; Di Giambenedetto, S Journal: HIV medicine Issue: Volume 19:Issue 7(2018) Page Start: 452 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Enterocytozoon bieneusi in AIDS: symptomatic relief and parasite changes after furazolidone. Issue 6 (June 1997) Authors: Dionisio, D; Manneschi, L I; Di Lollo, S; Orsi, A; Sterrantino, G; Meli, M; Gabbrielli, M; Tani, A; Papucci, A; Leoncini, F Journal: Journal of clinical pathology Issue: Volume 50:Issue 6(1997) Page Start: 472 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Morning dosing for dolutegravir‐related insomnia and sleep disorders. Issue 5 (1st August 2017) Authors: Capetti, AF; Di Giambenedetto, S; Latini, A; Sterrantino, G; De Benedetto, I; Cossu, MV; Gori, A Journal: HIV medicine Issue: Volume 19:Issue 5(2018) Page Start: e62 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Persistent damage to Enterocytozoon bieneusi, with persistent symptomatic relief, after combined furazolidone and albendazole in AIDS patients. Issue 10 (October 1998) Authors: Dionisio, D; Manneschi, L I; Di Lollo, S; Orsi, A; Sterrantino, G; Leoncini, F; Pozzi, M; Vinattieri, M A; Tani, A; Papucci, A Journal: Journal of clinical pathology Issue: Volume 51:Issue 10(1998) Page Start: 731 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Reduced risk of Efavirenz Discontinuation in Naïve Patients Starting First‐Line Antiretroviral Therapy with Single Tablet versus dual Tablet Regimen. Issue 5 (22nd September 2015) Authors: Fabbiani, M; Zaccarelli, M; Latini, A; Sterrantino, G; D'Ettorre, G; Grima, P; Mondi, A; Rossetti, B; Borchi, B; Giuliani, M; Antinori, A; De Luca, A; Di Giambenedetto, S Journal: HIV medicine Issue: Volume 17:Issue 5(2016:May) Page Start: 385 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗